期刊文献+

凋亡抑制蛋白Livin在胃癌治疗中的研究进展 被引量:3

暂未订购
导出
摘要 引言目前,对早期胃癌,手术切除仍然是治疗的主要手段,且预后较好;但大多胃癌发现时已属中晚期,而对晚期胃癌,全球尚未建立标准的治疗方案,现有的多种治疗手段仍无法改善患者的低存活率。凋亡抑制蛋白家族(inhibitors of
作者 赵桂梅
机构地区 解放军第
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第10期1201-1203,共3页 Cancer Research on Prevention and Treatment
  • 相关文献

参考文献3

二级参考文献28

  • 1Shi-Ting Bao,Shui-Qing Gui,Mu-Sheng Lin.Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(4):580-583. 被引量:28
  • 2周晟,万婕,刘聪,阮秋蓉,李娜萍.凋亡抑制基因livin与survivin在乳腺癌中的表达差异[J].中国组织化学与细胞化学杂志,2006,15(5):554-558. 被引量:13
  • 3Igney FH, Krammer PH. Death and anti-death : turnout resistance to apoptosis. Nat Rev Cancer, 2002, 2 : 277-288.
  • 4Kasof GM, Comes BC. Livin, a novel inhibitor of apoptosis protein family member. Biol Chem, 2001, 276:3238-3246.
  • 5Yagihashi A, Ohmura T, Asanuma K, et al. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer. Clin Chim Acta, 2005, 362:125- 130.
  • 6Mello CC, Conte D Jr. Revealing the world of RNA interference. Nature, 2004, 431: 338-342.
  • 7Tanabe H, Yagihashi A, Tsuji N, et al. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer. Lung Cancer, 2004, 46: 299-304.
  • 8Gazzaniga P, Gradilone A, Giuliani L, et al. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis- related genes in the progression of superficial bladder cancer. Ann Oncol, 2003, 14:85-90.
  • 9Crnkovic-Mertens I, Hoppe-Seyler F, Butz K. Induction of apoptosis in Tumor cells by siRNA mediated silencing of the livin/ ML-IAP/KIAP gene. Oncogene, 2003, 22: 8330-8336.
  • 10Crnkovie-Mertens I, Semzow J, Hoppe-Seyler F, et al. Isoformspecific silencing of the Livin gene by BNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa ceils. J Mol Med, 2006, 84: 232-240.

共引文献79

同被引文献17

  • 1刘平,王同杉,游思洪,葛红梅.livin在人胃癌组织中的表达及其沉默后对胃癌细胞凋亡的影响[J].中华肿瘤杂志,2007,29(8):570-574. 被引量:24
  • 2Benard J, Douc RS, Ahomadegbe JC. TP53 family members and human cancers [ J ]. Hum Mutat ,2003 ,21 : 182 - 191.
  • 3Sethi G, Sung B,Aggarwal BB. Nuclear factor-kappa B activation:from bench to bed side[ J]. Exp Biol Med(Maywood) ,2008,233 ( 1 ) :21 - 31.
  • 4Bourdon JC, Femandes K, Murray ZF, et al. p53 isoforms can regulate p53 transcriptional activity [ J ]. Genes Development, 2005,19 ( 18 ) : 2122 - 2137.
  • 5Hofstetter G,Berger A, Schuster E, et al. A133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer[ J]. Br J Cancer,2011,105(10) :1593 N 1599.
  • 6Bernard H, Garmy-Susini B, Ainaoui N, et al. The p53 isoform, 133p53c-,stimulates angiogenesis and tumour progression [ J 1. Onco- gene,2012,32 (17) :2150 - 2160.
  • 7Marcel V,Hainant P. p53 isoforms-a conspiracy to kidnap p53 tumor suppressor activity [ J ] ? Cell Mol Life Sci,2009,66 ( 3 ) : 391 - 406.
  • 8Bourdon JC. p53 and its isoforms in cancer[ J]. Cancer,2007,97:277 - 282.
  • 9Gui K, Kario K, Shimada K. Effects of long-acting ACE inbhibitor (temoeapril) and long-acting eaehannelloeker(amlodiping) on 24h ambulatory BP in elderly hypertensive patients [ J 1. J Hun Hyper- tens ,2001,23 ( 15 ) :643 - 648.
  • 10Psaty BM, Furberg CD, Kuller T, et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study [ J ]. Arch Intern Med, 2001,161(10) :1183 - 1192.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部